These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33792089)

  • 1. Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-β positivity.
    Tort-Merino A; Valech N; Laine M; Olives J; León M; Ecay-Torres M; Estanga A; Martínez-Lage P; Fortea J; Molinuevo JL; Sánchez-Valle R; Rodriguez-Fornells A; Rami L
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1037-1049. PubMed ID: 33792089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    Valech N; Mollica MA; Olives J; Tort A; Fortea J; Lleo A; Belén SS; Molinuevo JL; Rami L
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S87-98. PubMed ID: 26445275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
    Sannemann L; Bartels C; Brosseron F; Buerger K; Fliessbach K; Freiesleben SD; Frommann I; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kleineidam L; Lammerding D; Laske C; Munk MHJ; Perneczky R; Peters O; Priller J; Rauchmann BS; Rostamzadeh A; Roy-Kluth N; Schild AK; Schneider A; Schneider LS; Spottke A; Spruth EJ; Teipel S; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    J Alzheimers Dis; 2024; 100(1):193-205. PubMed ID: 38848176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
    Tort-Merino A; Valech N; Peñaloza C; Grönholm-Nyman P; León M; Olives J; Estanga A; Ecay-Torres M; Fortea J; Martínez-Lage P; Molinuevo JL; Laine M; Rodríguez-Fornells A; Rami L
    J Alzheimers Dis; 2017; 58(3):855-870. PubMed ID: 28505969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
    Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
    Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between the Subjective Cognitive Decline-Questionnaire's Scores, Gray Matter Volume, and Amyloid-β Levels.
    Valech N; Sánchez-Benavides G; Tort-Merino A; Coll-Padrós N; Olives J; León M; Falcon C; Molinuevo JL; Rami L
    J Alzheimers Dis; 2019; 72(4):1287-1302. PubMed ID: 31707366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    Valech N; Tort-Merino A; Coll-Padrós N; Olives J; León M; Rami L; Molinuevo JL
    J Alzheimers Dis; 2018; 61(2):689-703. PubMed ID: 29254090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
    Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
    J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle Cognitive Deficits Are Associated with Amyloid-β Positivity, but Not Severity of Self-Reported Decline: Results from the CoSCo Study.
    Ryu SY; Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW
    Dement Geriatr Cogn Disord; 2022; 51(2):159-167. PubMed ID: 35381591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    Tort-Merino A; Olives J; León M; Peñaloza C; Valech N; Santos-Santos MA; Càmara E; Grönholm-Nyman P; Martínez-Lage P; Fortea J; Molinuevo JL; Sánchez-Valle R; Laine M; Rodríguez-Fornells A; Rami L
    J Alzheimers Dis; 2019; 70(1):211-225. PubMed ID: 31177219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study.
    Sannemann L; Schild AK; Altenstein S; Bartels C; Brosseron F; Buerger K; Cosma NC; Fliessbach K; Freiesleben SD; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kobeleva X; Laske C; Metzger CD; Munk MHJ; Perneczky R; Peters O; Polcher A; Priller J; Rauchmann B; Rösch C; Rudolph J; Schneider A; Spottke A; Spruth EJ; Teipel S; Vukovich R; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    Alzheimers Res Ther; 2020 Oct; 12(1):131. PubMed ID: 33066827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume.
    Sánchez-Benavides G; Suárez-Calvet M; Milà-Alomà M; Arenaza-Urquijo EM; Grau-Rivera O; Operto G; Gispert JD; Vilor-Tejedor N; Sala-Vila A; Crous-Bou M; González-de-Echávarri JM; Minguillon C; Fauria K; Simon M; Kollmorgen G; Zetterberg H; Blennow K; Molinuevo JL;
    Neurobiol Aging; 2021 Aug; 104():24-31. PubMed ID: 33962331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects.
    Rami L; León M; Valech N; Coll-Padrós N; Bosch B; Olives J; Salinero A; Pérez-Millan A; Molinuevo JL; Sánchez-Valle R; Tort-Merino A
    Neuropsychology; 2023 Sep; 37(6):683-697. PubMed ID: 36729500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective cognitive decline and anxious/depressive symptoms during the COVID-19 pandemic: what is the role of stress perception, stress resilience, and β-amyloid?
    Akinci M; Sánchez-Benavides G; Brugulat-Serrat A; Peña-Gómez C; Palpatzis E; Shekari M; Deulofeu C; Fuentes-Julian S; Salvadó G; González-de-Echávarri JM; Suárez-Calvet M; Minguillón C; Fauria K; Molinuevo JL; Gispert JD; Grau-Rivera O; Arenaza-Urquijo EM;
    Alzheimers Res Ther; 2022 Sep; 14(1):126. PubMed ID: 36068641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline.
    Espenes R; Kirsebom BE; Eriksson C; Waterloo K; Hessen E; Johnsen SH; Selnes P; Fladby T
    J Alzheimers Dis; 2020; 75(3):879-890. PubMed ID: 32333584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
    Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.